MetaCap

Neogen Corporation Company Profile

NASDAQ: NEOGHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

10.55-0.30 (-2.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Neogen at a glance

Neogen Corporation (NASDAQ: NEOG) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company in the Health Care sector headquartered in Lansing, MI. Neogen is led by Mr. Mikhael Nassif and employs about 2,636 people. The company's shares have traded publicly since 1989.

At a market capitalization of $2.30 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0000711377, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Neogen do?

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Business description based on the company's public filings.

Company information

Legal name
Neogen Corporation
Ticker
NASDAQ: NEOG
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
CEO
Mr. Mikhael Nassif
Employees
2,636
Headquarters
620 Lesher Place, Lansing, MI, United States
Phone
517 372 9200
Website
neogen.com
IPO year
1989
SEC CIK
0000711377
Latest annual report
10-K · Jul 30, 2026

Companies similar to Neogen

NEOG peer companies
CompanyPrice% ChgMarket capCompare
CLDXCelldex Therapeutics Inc.27.42-1.93%$2.15Bvs NEOG
NTLAIntellia Therapeutics Inc.10.00+5.04%$1.40Bvs NEOG
QUITAchieve Life Sciences Inc.5.56-5.28%$573.25Mvs NEOG
QDELQuidelOrtho Corporation8.32-6.73%$570.86Mvs NEOG
MYGNMyriad Genetics Inc.5.46-1.44%$523.74Mvs NEOG
TKNOAlpha Teknova Inc.7.63-2.30%$479.95Mvs NEOG
NNNNAnbio Biotechnology Class A3.32-9.04%$145.72Mvs NEOG
ICCCImmuCell Corporation10.92-2.41%$99.28Mvs NEOG

Related